FORESIGHT Global Health Partners
FORESIGHT Global Health contributes to knowledge-sharing and solution building across sectors. With its focus on the intersection between in-depth health insights and socioeconomic research, it is the journalistic platform for thought leadership and dialogue on NCDs.
But we cannot fulfil this mission alone.
Support from our partners enables FORESIGHT Global Health to produce independent journalism on the prevention and control of NCDs through transformation of health systems worldwide.
Our Main Partner
Supporting the mission and journalistic principles behind FORESIGHT Global Health.
Merck, a leading science and technology company, operates across healthcare, life science and electronics, working to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. Merck believes that patient-centered health is core to optimal NCD management and is committed to finding and bringing to scale health solutions for NCDs.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents research-based pharmaceutical companies and associations across the globe. By engaging with health and research players, they facilitate the co-creation of sustainable policies and public-private partnerships that encourage the discovery of and access to medicines and vaccines to patients globally. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to drive the NCD agenda and help the global health community find solutions that improve global health.
Supporting the ambition of preventing and controlling non-communicable diseases through transformation of health systems worldwide.